Key Principles and Recommended Regimens for First-line Antiretroviral Therapy

  • Author: Paul E. Sax, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 10/5/18 (What's New)

Summary

  • 3 boosted PIs are currently included among choices for first-line therapy in US and European guidelines
  • Atazanavir is included as an alternative option in the DHHS and EACS guidelines[DHHS ART; EACS ART]
  • Darunavir is included as an alternative option in the DHHS, IAS-USA, and EACS guidelines[DHHS ART; IAS-USA ART; EACS ART]
  • Boosted Atazanavir-Based Initial Therapy
      Atazanavir + Ritonavir Initial Therapy
        Atazanavir/Cobicistat-Based Initial Therapy
        Boosted Darunavir-Based Initial Therapy
          Darunavir/Ritonavir Initial Therapy
            Darunavir/Cobicistat-Based Initial Therapy
            Lopinavir/Ritonavir-Based Initial Therapy

            Action required